STATISTICAL REVIEW OF CLINICAL RESEARCH INDUSTRY

By GEETANJALI PARABPRIYANKA MUDLIARSHIVANGI PATILSRABANI BISWASTANMAY SHINDECLASS- PGDAIB

04/09/231

INTRODUCTION

Clinical research may be defined as organized research conducted on human beings intended to provide adequate information on drug use as a therapeutic agent on its safety ,efficacy and its adverse effects.

Globally there is a paradigm shift in the pharmaceutical market & nearly two third of R& D costs go into drug development .

Of this,70% time and resources are spent in clinical research.

04/09/23

2

Overall country attractiveness index in clinical research

04/09/23

3

U.S. SPONSORED CLINICAL TRIALS MARKET,2003-2011($BILLIONS)

04/09/23

4

Country share of registered clinical trials in Asia

India is close second to China (~41%) with 36% clinical trials being registered from 2002 to 2008.

Singapore and Pakistan holds third and fourth position respectively in 5 nations comparison study. Sri Lanka has only 0.3% share in the pie.

04/09/23

5

India - 463.33% growth from 2002 to 2008 in terms of clinical trials .

China - second with 365.56% rise in the same period.

Overall statistics -China remains number 1 for clinical trial destination amongst 4 countries.

Clinical trials in Asia on a rise

04/09/23

6

Indian Scenario

04/09/237

Why India A Choice For CR ???

04/09/23

8

Evolution of CR in INDIA 1995-2015

04/09/23

9

Therapeutic area wise distribution

04/09/23

10

Clinical Studies for USFDA Submission (India)

04/09/23

11

Clinical Research market size

04/09/23

12

Clinical Research Segmental Players in INDIA

04/09/23

13

Clinical trials conducted by MNC’s

04/09/23

14

MARKET SHARE OF CROs

04/09/23

15

Estimated CR Industry Growth in INDIA

04/09/23

16

Revenue Record

Projected figures in respect of revenue, human power and patient load for clinical research in India

2003 2008 2010

Value (million USD) 50 200 1000

Revenue (crore INR) 75 300 875

Full time staff requirement

800 4000 20,000

Site-staff requirement 1500 6000 30,000

Patient load 10,000 50,000 300,000

Source: McKinsey report

04/09/23

17

Various Job Sectors for CR in INDIA

04/09/23

18

SCOPE AND FUTURE

04/09/2319

Demand –Supply Gap in INDIA 2010

04/09/23

20

SCOPE

The forecasted size of the clinical research market in India by 2010 varies from $300 million (Ernst & Young) to $1.5-$2 billion (McKinsey). This range reflects India's potential to be a major global player in clinical trials.

India is fast-emerging as an attractive destination for clinical trials. Today, the market value of clinical research outsourced to India is estimated at more than US$300 million compared with US$ 140 million in 2006 and it is expanding at 40% over last 3 years. By 2010, it is projected to be of US$1.5 – 2.0 billion.

In 2005% only 1% of the global trials were conducted in India and it is expected to conduct 15% of the global trials by 2011. The matter of fact is that, India's clinical research industry is still relatively small in size compared to the global clinical trial industry estimated at around $30 billion.

04/09/23

21

OPPORTUNITIES IN CR

India has 300 universities, over 750 graduate and post-graduate programs, and about 50 million collage graduates.

Presently there are only 40 institutes offer courses in clinical research and provide 5000 trained professionals annually. This is inadequate as industry needs approximately 11,000 professionals annually.

By 2011, India will require 50,000 professionals to support its booming CR industry.1. INDIA Vital Stats

2. No. of universities: 300

3. No. of graduate / post-graduate programs offered:

750

4. No of graduate students: 50mn

5. No. of CR professionals trained / yr: 5000

6. No. of CR professionals required / yr: 11000

7. No. of medical professionals: 7, 00,000

8. No. of ICH-GCP trained investigators: 1000

04/09/23

22

CONCLUSION

04/09/23

23

REFERENCES

04/09/23

24

04/09/23

25

Thank You!!